Forever, For A Price
THE WEEK|August 06, 2017

The immortality industry is booming, thanks to massive funding and extensive research.

Emily Hill
Forever, For A Price

Imagine a world in which you are 90 years old and nowhere near middle-aged. An app on your phone has hacked your DNA code, so you know exactly when to go to the doctor to receive gene therapy to prevent all the diseases you don’t yet have. Every evening you sync your brain-mapping device with the Cloud, so even if you had a fatal accident you would still be able to cheat death—every detail of your life would simply be downloaded to one of the perfect silicon versions you had made of yourself, ensuring you last until at least your 1,000th birthday.

This may sound like science fiction but it could be your fate, provided you can afford it. If current research develops into medicine, in the future the super-rich won’t simply be able to buy the best things in life, they will be able to buy life itself by transforming themselves into a bio-engineered super-race, capable of living, if not forever, then for vastly longer than the current life expectancy.

The science of turning back the clock has never been more advanced. In Boston, a drug capable of reversing half a lifetime of ageing in mice is about to be tested on humans in a medical trial monitored by NASA. NMN (nicotinamide mononucleotide) is a compound found naturally in broccoli that boosts levels of NAD (nicotinamide adenine dinucleotide), a protein involved in energy production that depletes as we get older. Professor David Sinclair, who headed the initial research at Australia’s University of New South Wales, doses himself with 500mg daily and claims that he has already become more youthful. According to blood tests analysing the state of the 48-year-old’s cells, prior to taking the pills Sinclair was in the same physical shape as a 57-year-old, but now he is “31.4”.

This story is from the August 06, 2017 edition of THE WEEK.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

This story is from the August 06, 2017 edition of THE WEEK.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

MORE STORIES FROM THE WEEKView All
Between hospital and home
THE WEEK India

Between hospital and home

Transitional care centres can add a lot to India's health care system

time-read
3 mins  |
May 05, 2024
EFFORT VS EFFECT
THE WEEK India

EFFORT VS EFFECT

The government's attempts to ensure quality drugs is evident, but how well new policies can be monitored on the ground remains to be seen

time-read
7 mins  |
May 05, 2024
A way to let go of fear
THE WEEK India

A way to let go of fear

Accepting the use of adult diapers is a journey with various stages-denial, concealment, rejection and reluctance

time-read
3 mins  |
May 05, 2024
Mandeeps & a miracle
THE WEEK India

Mandeeps & a miracle

Two strangers, one deadly disease and an act of kindness. How Mandeep Mann saved Mandeep Singh, an acute leukaemia patient, by donating his stem cells

time-read
10+ mins  |
May 05, 2024
The A, B, C of cosmetic surgery
THE WEEK India

The A, B, C of cosmetic surgery

Between eight to 10 lakh cosmetic surgeries happen in India every year. Who is an ideal candidate, and what are the risks and results you can expect?

time-read
6 mins  |
May 05, 2024
Vaccines and meningitis
THE WEEK India

Vaccines and meningitis

In sub-Saharan Africa, from Senegal in the west to Ethiopia in the east, and encompassing the northern part of Nigeria, there exists a region known as the African Meningitis Belt (AMB).

time-read
1 min  |
May 05, 2024
Celebrating diversity and inclusivity
THE WEEK India

Celebrating diversity and inclusivity

As Indians battle it out in our nation's 18th general election, it is again time for voters to reflect on the \"Idea of India\"-or rather, on two duelling ideas of India that are now before us and between which the nation must choose at the ballot box.

time-read
3 mins  |
May 05, 2024
Defendant: an Hermès handbag
THE WEEK India

Defendant: an Hermès handbag

When Hermès was hit with a class-action lawsuit last month for \"antitrust\" activities, it didn't see it coming. Most of the luxury world has all eyes on this suit, filed by two interested consumers who claim they were denied a purchase, and whether it would go to trial.

time-read
2 mins  |
May 05, 2024
A legacy, bound
THE WEEK India

A legacy, bound

Amal Allana's biography of her father, Ebrahim Alkazi, is as much personal as it is historical

time-read
4 mins  |
May 05, 2024
Cutting-edge chronicle
THE WEEK India

Cutting-edge chronicle

In his new book, Salman Rushdie's pen is mightier than the knife

time-read
6 mins  |
May 05, 2024